ACM
AMGN icon

Avalon Capital Management’s Amgen AMGN Stock Holding History

Avalon Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,357
Closed -$4.35M – 132
2026
Q1 		$4.35M Sell
12,357
-16,552
-57% -$5.9M 1.23% 22
2025
Q4 		$9.46M Buy
+28,909
New +$9.17M 2.26% 12
2016
Q2 		– Sell
-3,144
Closed -$471K – 71
2016
Q1 		$471K Buy
+3,144
New +$467K 0.38% 51

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Avalon Capital Management's AMGN Position: Q2 2026 in Review

Avalon Capital Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 12,357 shares — an estimated $4.35M sold.

Avalon Capital Management first reported a position in AMGN in Q1 2016 and held it in 3 quarters. The position peaked at $9.46M in Q4 2025. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Avalon Capital Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Avalon Capital Management sold 12,357 Amgen shares in Q2 2026, an estimated $4.35M.
  • Avalon Capital Management first reported a position in Amgen in Q1 2016 and held it in 3 quarters.
  • Avalon Capital Management's Amgen position peaked at $9.46M in Q4 2025.
  • 3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Avalon Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.